Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri kdunleavy Wed, 03/01/2023 – 16:25 More: Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri Source: fierce
read moreICER dials up recommended price range for Eisai’s Leqembi—but still calls for sizable discount aliu Wed, 03/01/2023 – 14:01 More: ICER dials up recommended price range for Eisai's Leqembi—but still calls for sizable discount Source: fierce
read moreJohnson & Johnson logs 57 layoffs in Pennsylvania as Kenvue spinoff nears fkansteiner Wed, 03/01/2023 – 13:36 More: Johnson & Johnson logs 57 layoffs in Pennsylvania as Kenvue spinoff nears Source: fierce
read moreRegeneron, Sanofi’s Kevzara becomes first biologic approved for polymyalgia rheumatica zbecker Wed, 03/01/2023 – 10:46 More: Regeneron, Sanofi's Kevzara becomes first biologic approved for polymyalgia rheumatica Source: fierce
read moreMerck’s Keytruda bounces back from pair of trial flops with interim win in earlier lung cancer fkansteiner Wed, 03/01/2023 – 10:32 More: Merck's Keytruda bounces back from pair of trial flops with interim win in earlier lung cancer Source: fierce
read moreThe programme will support new European and national strategies to reduce exposure to hazardous chemicals More: Industry research boost from University of Aberdeen Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals